Accordingly, METTL3 promoted resistance to gefitinib in NSCLC through regulation of two core autophagy genes, Atg5 and Atg7 (Glick et al., 2010; Liu S. et al., 2020). This evidence concerns the gene ATG7 and non-small cell lung carcinoma.